Chi-Ping Day

2.3k total citations · 1 hit paper
6 papers, 582 citations indexed

About

Chi-Ping Day is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Chi-Ping Day has authored 6 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Immunology. Recurrent topics in Chi-Ping Day's work include RNA modifications and cancer (1 paper), Cancer Research and Treatments (1 paper) and CAR-T cell therapy research (1 paper). Chi-Ping Day is often cited by papers focused on RNA modifications and cancer (1 paper), Cancer Research and Treatments (1 paper) and CAR-T cell therapy research (1 paper). Chi-Ping Day collaborates with scholars based in United States, Taiwan and United Kingdom. Chi-Ping Day's co-authors include Glenn Merlino, Terry Van Dyke, Mien‐Chie Hung, Ka Yin Kwong, Shao‐Chun Wang, Yan M. Li, Yiyu Zou, Keishi Makino, Guillermina Lozano and Hsiu-Ming Shih and has published in prestigious journals such as Cell, Nature Communications and Cancer Research.

In The Last Decade

Chi-Ping Day

6 papers receiving 570 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges

2015 453 citations Chi-Ping Day, Glenn Merlino et al. Cell profile →

Peers

Countries citing papers authored by Chi-Ping Day

Since Specialization

Citations

This map shows the geographic impact of Chi-Ping Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi-Ping Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi-Ping Day more than expected).

Fields of papers citing papers by Chi-Ping Day

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi-Ping Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi-Ping Day. The network helps show where Chi-Ping Day may publish in the future.

Co-authorship network of co-authors of Chi-Ping Day

This figure shows the co-authorship network connecting the top 25 collaborators of Chi-Ping Day. A scholar is included among the top collaborators of Chi-Ping Day based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi-Ping Day. Chi-Ping Day is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	A machine learning model reveals expansive downregulation of ligand-receptor interactions that enhance lymphocyte infiltration in melanoma with developed resistance to immune checkpoint blockade 2024 ·Nature Communications ·(unknown), Binbin Wang, (unknown), (unknown), Matthew Nagy, Sushant Patkar, Ingrid Ferreira, Chi-Ping Day, Kun Wang, Eytan Ruppin	7
2	Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges breakdown → 2015 ·Cell ·Chi-Ping Day, Glenn Merlino, Terry Van Dyke	453
3	Meeting report: The future of preclinical mouse models in melanoma treatment is now 2013 ·Pigment Cell & Melanoma Research ·Glenn Merlino, Keith T. Flaherty, Nicolas Acquavella, Chi-Ping Day, Andrew E. Aplin, Sheri L. Holmen, Suzanne L. Topalian, Terry Van Dyke, Meenhard Herlyn	25
4	Upregulation of IKKα/IKKβ by integrin-linked kinase is required for HER2/neu-induced NF-κB antiapoptotic pathway 2004 ·Oncogene ·Keishi Makino, Chi-Ping Day, Shao‐Chun Wang, Yan M. Li, Mien‐Chie Hung	38
5	Adenoviral E1A Targets Mdm4 to Stabilize Tumor Suppressor p53 2004 ·Cancer Research ·Zheng Li, Chi-Ping Day, Jer-Yen Yang, Wen-Bin Tsai, Guillermina Lozano, Hsiu-Ming Shih, Mien‐Chie Hung	29
6	The suppression of colon cancer cell growth in nude mice by targetingβ-catenin/TCF pathway 2002 ·Oncogene ·Ka Yin Kwong, Yiyu Zou, Chi-Ping Day, Mien‐Chie Hung	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact